GB2119791A - Aziridine derivative - Google Patents

Aziridine derivative Download PDF

Info

Publication number
GB2119791A
GB2119791A GB08310523A GB8310523A GB2119791A GB 2119791 A GB2119791 A GB 2119791A GB 08310523 A GB08310523 A GB 08310523A GB 8310523 A GB8310523 A GB 8310523A GB 2119791 A GB2119791 A GB 2119791A
Authority
GB
United Kingdom
Prior art keywords
formula
aziridine
nitromethylene
methyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08310523A
Other versions
GB2119791B (en
GB8310523D0 (en
Inventor
John Bradshaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB08310523A priority Critical patent/GB2119791B/en
Publication of GB8310523D0 publication Critical patent/GB8310523D0/en
Publication of GB2119791A publication Critical patent/GB2119791A/en
Application granted granted Critical
Publication of GB2119791B publication Critical patent/GB2119791B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/12Radicals substituted by nitrogen atoms not forming part of a nitro radical

Abstract

The aziridine derivative N-methyl- alpha -(nitromethylene)-1-aziridine- methanamine is a useful intermediate for use in the preparation of ranitidine.

Description

SPECIFICATION Aziridine derivative This invention relates to an aziridine derivative.
The furan derivative of formula (I)
which is known as ranitidine is disclosed in British Patent Specification No. 1 565966 as a potent and selective H2-antagonist.
Our British Patent application No. 81 00477 (publication No. 2067991A) describes and ciaims a process for the preparation of the furan derivative of formula (I) which comprises reacting a thiol of formula (II)
with an alkylating agent of formula (III)
where R1 is the group -CH2OH 2L, in which L is a leaving group, and R2 is a hydrogen atom, or R, and R2, together with the nitrogen atom to which they are attached, form an ethyleneimino group.
This process is a novel and useful method for the preparation of the compound ranitidine.
The present invention provides the compound defined by formula (III) above in which R,R2N is an ethyleneimino group, i.e. N-methyl-a- (nitromethylene)- 1 -aziridinemethanamine of formula (IV)
The aziridine derivative of formula (IV) may be prepared by reaction of ethyleneimine with a nitroethenamine of formula (V)
in which L" is a leaving group, for example a C14 alkoxy group or a C1 < alkylthio group, preferably methylthio. The reaction may be carried out in a suitable aprotic solvent such as acetonitrile.
The invention is illustrated by the following example: Example N-Methyl-a-(nitromethylene)- 1 -aziridinemethanamine A solution of ethyleneimine (0.47 g) and N ethyl(1 -methylthio)-2-nitroetheneamine (1.48 g) in acetonitrile (5 ml) was stirred at room temperature for 2 days. The suspension was evaporated in vacuo at room temperature and the residue extracted with hot ethyl acetate (100 ml).
Evaporation of the extract in vacuo gave a residue which was suspended in ethyl acetate (50 ml) and filtered. The filtrate was evaporated to ca. 5 ml and chromatographed (silica/ethyl acetate). The appropriate eluate [TLC (silica/ethyl acetate) Rf 0.28] was evaporated in vacuo to give the title compound (0.33 g), m.p. 1181190.
Claims
1. N-Methyl-a-(nitromethylene)-1-aziridine- methanamine.
2. A process for the preparation of N-methyl-a- (nitromethylene)- 1 -aziridine-methanamine which comprises reacting ethyleneimine with a nitroethenamine of formula (V)
where L" is a leaving group.
3. A process as claimed in claim 2 wherein L" is a C,, alkoxy group or a C14 alkylthio group.
4. A process for the preparation of N-methyl-a- (nitromethylene)-1 -aziridine-methanamine substantially as described with particular reference to the example.
5. N-Methyl-a-(nitromethylene)-1 -aziridine- methanamine when prepared by a process as claimed in any of claims 2 to 4.
**WARNING** end of DESC field may overlap start of CLMS **.

Claims (5)

**WARNING** start of CLMS field may overlap end of DESC **. SPECIFICATION Aziridine derivative This invention relates to an aziridine derivative. The furan derivative of formula (I) which is known as ranitidine is disclosed in British Patent Specification No. 1 565966 as a potent and selective H2-antagonist. Our British Patent application No. 81 00477 (publication No. 2067991A) describes and ciaims a process for the preparation of the furan derivative of formula (I) which comprises reacting a thiol of formula (II) with an alkylating agent of formula (III) where R1 is the group -CH2OH 2L, in which L is a leaving group, and R2 is a hydrogen atom, or R, and R2, together with the nitrogen atom to which they are attached, form an ethyleneimino group. This process is a novel and useful method for the preparation of the compound ranitidine. The present invention provides the compound defined by formula (III) above in which R,R2N is an ethyleneimino group, i.e. N-methyl-a- (nitromethylene)- 1 -aziridinemethanamine of formula (IV) The aziridine derivative of formula (IV) may be prepared by reaction of ethyleneimine with a nitroethenamine of formula (V) in which L" is a leaving group, for example a C14 alkoxy group or a C1 < alkylthio group, preferably methylthio. The reaction may be carried out in a suitable aprotic solvent such as acetonitrile. The invention is illustrated by the following example: Example N-Methyl-a-(nitromethylene)- 1 -aziridinemethanamine A solution of ethyleneimine (0.47 g) and N ethyl(1 -methylthio)-2-nitroetheneamine (1.48 g) in acetonitrile (5 ml) was stirred at room temperature for 2 days. The suspension was evaporated in vacuo at room temperature and the residue extracted with hot ethyl acetate (100 ml). Evaporation of the extract in vacuo gave a residue which was suspended in ethyl acetate (50 ml) and filtered. The filtrate was evaporated to ca. 5 ml and chromatographed (silica/ethyl acetate). The appropriate eluate [TLC (silica/ethyl acetate) Rf 0.28] was evaporated in vacuo to give the title compound (0.33 g), m.p. 1181190. Claims
1. N-Methyl-a-(nitromethylene)-1-aziridine- methanamine.
2. A process for the preparation of N-methyl-a- (nitromethylene)- 1 -aziridine-methanamine which comprises reacting ethyleneimine with a nitroethenamine of formula (V)
where L" is a leaving group.
3. A process as claimed in claim 2 wherein L" is a C,, alkoxy group or a C14 alkylthio group.
4. A process for the preparation of N-methyl-a- (nitromethylene)-1 -aziridine-methanamine substantially as described with particular reference to the example.
5. N-Methyl-a-(nitromethylene)-1 -aziridine- methanamine when prepared by a process as claimed in any of claims 2 to 4.
GB08310523A 1980-01-08 1983-04-19 Aziridine derivative Expired GB2119791B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08310523A GB2119791B (en) 1980-01-08 1983-04-19 Aziridine derivative

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8000580 1980-01-08
GB08310523A GB2119791B (en) 1980-01-08 1983-04-19 Aziridine derivative

Publications (3)

Publication Number Publication Date
GB8310523D0 GB8310523D0 (en) 1983-05-25
GB2119791A true GB2119791A (en) 1983-11-23
GB2119791B GB2119791B (en) 1984-05-31

Family

ID=26274064

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08310523A Expired GB2119791B (en) 1980-01-08 1983-04-19 Aziridine derivative

Country Status (1)

Country Link
GB (1) GB2119791B (en)

Also Published As

Publication number Publication date
GB2119791B (en) 1984-05-31
GB8310523D0 (en) 1983-05-25

Similar Documents

Publication Publication Date Title
Do Minh et al. Reactions of phthalaldehyde with ammonia and amines
IL97565A0 (en) Process for the preparation of chlorothiazole derivatives
KR940006629B1 (en) Process for preparing amino disulfide thiol exchange products
JPH01193282A (en) Disulfur analogue of ll-e 33288
KR890011904A (en) Synthesis of 6-methylene derivative of androstar-1,4, -diene-3,17-dione
DE2733867C3 (en) Oleandomycin derivatives and antibacterial agents containing these compounds
CA1095035A (en) Process for the production of rifamycins
IE60470B1 (en) Pyrimidine derivatives, a process for their manufacture and medicaments containing said derivatives
GB2119791A (en) Aziridine derivative
EP0285681B1 (en) Process for the preparation of nitroethylene derivatives
EP0064869B1 (en) Process for the preparation of a furan derivative
US4399293A (en) Process for the preparation of a furan derivative
FI80700B (en) FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA MITOMYCINANALOGER.
KR840002002B1 (en) Process for preparing aziridine derivatives
US4460506A (en) Nitrovinyl aziridine derivative
FI80450B (en) FRAME FOR EXAMINATION OF N- [2 - // 5 - / (DIMETHYLAMINO) METHYL] -2-FURANYLMETHYL / -THIO / EECL / -N&#39;METHYL-2-NITRO-1,1-ETENDIAMINE.
Sudarsanam et al. Nitroimidazoles: Part XI. some halonitro-& dinitroimidazoles
IL93393A (en) Process for the preparation of omicron-carboxypyridyl and omicron-carboxyquinolyl- imidazolinones
KR930003075B1 (en) PROCESS FOR PREPARATION OF CRYSTALLINE 7-(DIMETHYLAMINO METHYLENE) AMINO-9a-METHOXYMITOSANE
KR860001817B1 (en) Process for the preparation of ethyleneimine derivatives
US4552967A (en) Process for the synthesis of intermediates in the preparation of diaminopyridines
SU1366517A1 (en) Method of obtaining 3-(beta-d-glucopyranosyl)-4-oxyhexahydropyrimidine-2-thion
SU1414847A1 (en) Method of producing 1,4,7,10,13,16-hexathiacyclooctadecane
KR810000812B1 (en) Process for preparing new rifamycin derivatives
Anzai et al. Mechanism of the phenoxycarbonylation of 2?, 3?? O? isopropylidenadenosine

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940108